FGF21 can protect animals from diet-induced obesity and reduce hepatic lipid accumulation, enhance glucose metabolism, and thus prevent hepatic steatosis, fibrosis, and NAFLD when administered to diabetic rodents8–10,12,15,16. This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.